Cumberland Pharmaceuticals (CPIX) vs Corbus Pharmaceuticals (CRBP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Corbus Pharmaceuticals (CRBP) over the past year, gaining 93.5% versus a loss of 62.4%. Over five years, CPIX leads with a +151.5% price change compared with -82.1% for CRBP. Corbus Pharmaceuticals is the larger company by market cap ($106.2 million vs $103.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPIX | CRBP |
|---|---|---|
| Share price | $6.89 | $5.49 |
| Market cap | $103.23M | $106.18M |
| 1-day change | -3.50% | -5.02% |
| YTD return | +73.12% | -32.56% |
| 1-year return | +93.54% | -62.42% |
| 5-year return | +151.46% | -82.06% |
| Forward P/E | 49.21 | — |
| EPS (TTM) | $-0.62 | $-6.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.28 | $20.56 |
| 52-week low | $1.85 | $5.47 |
| Distance from 52-week high | -25.75% | -73.30% |
| Average volume | 87.71K | 739.11K |
| Shares outstanding | 14.98M | 19.34M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPIX has outperformed CRBP by 156.0 percentage points over the past year.
CPIX vs CRBP FAQ
Which is bigger, Cumberland Pharmaceuticals or Corbus Pharmaceuticals?
Corbus Pharmaceuticals (CRBP) is larger, with a market capitalization of $106.18M compared with $103.23M for Cumberland Pharmaceuticals (CPIX).
Which stock has performed better over the past year, CPIX or CRBP?
CPIX returned +93.54% over the past 12 months, compared with -62.42% for CRBP (price return, excluding dividends). Past performance does not predict future results.
Are Cumberland Pharmaceuticals and Corbus Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.